Published in RNA on March 29, 2011
Emerging therapeutics targeting mRNA translation. Cold Spring Harb Perspect Biol (2012) 1.04
mRNAs containing the histone 3' stem-loop are degraded primarily by decapping mediated by oligouridylation of the 3' end. RNA (2012) 0.98
Two-headed tetraphosphate cap analogs are inhibitors of the Dcp1/2 RNA decapping complex. RNA (2016) 0.78
Synthesis, properties, and biological activity of boranophosphate analogs of the mRNA cap: versatile tools for manipulation of therapeutically relevant cap-dependent processes. Nucleic Acids Res (2014) 0.78
Cap analogs modified with 1,2-dithiodiphosphate moiety protect mRNA from decapping and enhance its translational potential. Nucleic Acids Res (2016) 0.76
Synthesis and evaluation of fluorescent cap analogues for mRNA labelling. RSC Adv (2013) 0.76
Applications of Phosphate Modification and Labeling to Study (m)RNA Caps. Top Curr Chem (J) (2017) 0.75
Cloning and expression of the gene for bacteriophage T7 RNA polymerase. Proc Natl Acad Sci U S A (1984) 13.68
The enzymes and control of eukaryotic mRNA turnover. Nat Struct Mol Biol (2004) 7.57
Association of the yeast poly(A) tail binding protein with translation initiation factor eIF-4G. EMBO J (1996) 7.28
Eukaryotic mRNA decapping. Annu Rev Biochem (2004) 6.35
AU-rich elements and associated factors: are there unifying principles? Nucleic Acids Res (2006) 6.22
Messenger RNA degradation in eukaryotes. Cell (1993) 6.13
Human Dcp2: a catalytically active mRNA decapping enzyme located in specific cytoplasmic structures. EMBO J (2002) 6.08
Identification of a human decapping complex associated with hUpf proteins in nonsense-mediated decay. Mol Cell Biol (2002) 5.80
Metabolism and regulation of canonical histone mRNAs: life without a poly(A) tail. Nat Rev Genet (2008) 5.42
Cocrystal structure of the messenger RNA 5' cap-binding protein (eIF4E) bound to 7-methyl-GDP. Cell (1997) 4.75
Multiple processing body factors and the ARE binding protein TTP activate mRNA decapping. Mol Cell (2005) 4.60
Adenylyl imidodiphosphate, an adenosine triphosphate analog containing a P--N--P linkage. Biochemistry (1971) 4.28
The mammalian exosome mediates the efficient degradation of mRNAs that contain AU-rich elements. EMBO J (2002) 4.13
The hDcp2 protein is a mammalian mRNA decapping enzyme. Proc Natl Acad Sci U S A (2002) 3.97
The control of mRNA decapping and P-body formation. Mol Cell (2008) 3.58
Degradation of histone mRNA requires oligouridylation followed by decapping and simultaneous degradation of the mRNA both 5' to 3' and 3' to 5'. Genes Dev (2008) 3.30
Structure of translation factor eIF4E bound to m7GDP and interaction with 4E-binding protein. Nat Struct Biol (1997) 3.14
mRNA decapping in yeast requires dissociation of the cap binding protein, eukaryotic translation initiation factor 4E. Mol Cell Biol (2000) 3.06
An mRNA stability complex functions with poly(A)-binding protein to stabilize mRNA in vitro. Mol Cell Biol (1999) 2.57
Biophysical studies of eIF4E cap-binding protein: recognition of mRNA 5' cap structure and synthetic fragments of eIF4G and 4E-BP1 proteins. J Mol Biol (2002) 2.53
Analysis of recombinant yeast decapping enzyme. RNA (2003) 2.50
The scavenger mRNA decapping enzyme DcpS is a member of the HIT family of pyrophosphatases. EMBO J (2002) 2.46
An NMD pathway in yeast involving accelerated deadenylation and exosome-mediated 3'-->5' degradation. Mol Cell (2003) 2.41
Translation factors promote the formation of two states of the closed-loop mRNP. Nature (2008) 2.31
mRNA stabilization by poly(A) binding protein is independent of poly(A) and requires translation. Genes Dev (1998) 2.10
Crystal structure and functional analysis of Dcp2p from Schizosaccharomyces pombe. Nat Struct Mol Biol (2005) 1.88
Functional characterization of the mammalian mRNA decapping enzyme hDcp2. RNA (2003) 1.88
mRNA decapping is promoted by an RNA-binding channel in Dcp2. Mol Cell (2008) 1.50
Synthesis and properties of mRNAs containing the novel "anti-reverse" cap analogs 7-methyl(3'-O-methyl)GpppG and 7-methyl (3'-deoxy)GpppG. RNA (2001) 1.48
Association of yeast Upf1p with direct substrates of the NMD pathway. Proc Natl Acad Sci U S A (2007) 1.40
Structural features of human initiation factor 4E, studied by X-ray crystal analyses and molecular dynamics simulations. J Mol Biol (2003) 1.37
Novel "anti-reverse" cap analogs with superior translational properties. RNA (2003) 1.18
Transcript-specific decapping and regulated stability by the human Dcp2 decapping protein. Mol Cell Biol (2007) 1.17
Differential inhibition of mRNA degradation pathways by novel cap analogs. J Biol Chem (2005) 1.15
Phosphorothioate cap analogs increase stability and translational efficiency of RNA vaccines in immature dendritic cells and induce superior immune responses in vivo. Gene Ther (2010) 1.14
Plasmid DNA- and messenger RNA-based anti-cancer vaccination. Immunol Lett (2007) 1.07
The structural changes of T7 RNA polymerase from transcription initiation to elongation. Curr Opin Struct Biol (2009) 1.04
Gene expression networks: competing mRNA decay pathways in mammalian cells. Biochem Soc Trans (2009) 0.96
Nucleoside and oligonucleoside boranophosphates: chemistry and properties. Chem Rev (2007) 0.95
Phosphorothioate cap analogs stabilize mRNA and increase translational efficiency in mammalian cells. RNA (2007) 0.93
Regulation of pathways of mRNA destabilization and stabilization. Prog Nucleic Acid Res Mol Biol (2002) 0.93
Synthesis and biochemical properties of novel mRNA 5' cap analogs resistant to enzymatic hydrolysis. Nucleosides Nucleotides Nucleic Acids (2005) 0.85
Phosphoroselenoate dinucleotides for modification of mRNA 5' end. Chembiochem (2009) 0.81
Protection of cap-dependent protein synthesis in vivo and in vitro with an eIF4G-1 variant highly resistant to cleavage by Coxsackievirus 2A protease. J Biol Chem (2002) 0.80
MicroRNA inhibition of translation initiation in vitro by targeting the cap-binding complex eIF4F. Science (2007) 4.33
Biophysical studies of eIF4E cap-binding protein: recognition of mRNA 5' cap structure and synthetic fragments of eIF4G and 4E-BP1 proteins. J Mol Biol (2002) 2.53
Drosophila miR2 primarily targets the m7GpppN cap structure for translational repression. Mol Cell (2009) 1.82
Translation initiation factor eIF4G-1 binds to eIF3 through the eIF3e subunit. J Biol Chem (2006) 1.74
Adenosine 5'-tetraphosphate is a highly potent purinergic endothelium-derived vasoconstrictor. Circ Res (2008) 1.61
Interaction between the NH2-terminal domain of eIF4A and the central domain of eIF4G modulates RNA-stimulated ATPase activity. J Biol Chem (2004) 1.52
Transcriptome characterization by RNA sequencing identifies a major molecular and clinical subdivision in chronic lymphocytic leukemia. Genome Res (2013) 1.51
mTOR-dependent stimulation of the association of eIF4G and eIF3 by insulin. EMBO J (2006) 1.51
mRNA decapping is promoted by an RNA-binding channel in Dcp2. Mol Cell (2008) 1.50
Translation of a small subset of Caenorhabditis elegans mRNAs is dependent on a specific eukaryotic translation initiation factor 4E isoform. Mol Cell Biol (2005) 1.40
Contribution of trans-splicing, 5' -leader length, cap-poly(A) synergism, and initiation factors to nematode translation in an Ascaris suum embryo cell-free system. J Biol Chem (2004) 1.31
Disrupted microRNA expression caused by Mecp2 loss in a mouse model of Rett syndrome. Epigenetics (2010) 1.26
Novel "anti-reverse" cap analogs with superior translational properties. RNA (2003) 1.18
Differential inhibition of mRNA degradation pathways by novel cap analogs. J Biol Chem (2005) 1.15
Influence of electric charge variation at residues 209 and 159 on the interaction of eIF4E with the mRNA 5' terminus. Biochemistry (2004) 1.15
Nematode m7GpppG and m3(2,2,7)GpppG decapping: activities in Ascaris embryos and characterization of C. elegans scavenger DcpS. RNA (2004) 1.13
Temporal processing deficits in high-functioning children with autism. Br J Psychol (2004) 1.08
Stopped-flow kinetic analysis of eIF4E and phosphorylated eIF4E binding to cap analogs and capped oligoribonucleotides: evidence for a one-step binding mechanism. J Biol Chem (2006) 1.04
Novel cap analogs for in vitro synthesis of mRNAs with high translational efficiency. RNA (2004) 1.04
Helicobacter pylori AlpA and AlpB bind host laminin and influence gastric inflammation in gerbils. Infect Immun (2011) 1.03
Positive heat capacity change upon specific binding of translation initiation factor eIF4E to mRNA 5' cap. Biochemistry (2002) 1.02
Discrimination between mono- and trimethylated cap structures by two isoforms of Caenorhabditis elegans eIF4E. EMBO J (2002) 1.02
Specificity of recognition of mRNA 5' cap by human nuclear cap-binding complex. RNA (2005) 1.01
Binding specificities and potential roles of isoforms of eukaryotic initiation factor 4E in Leishmania. Eukaryot Cell (2006) 1.01
Thermodynamics of mRNA 5' cap binding by eukaryotic translation initiation factor eIF4E. Biochemistry (2004) 1.00
Cross-talk between snurportin1 subdomains. Mol Biol Cell (2005) 1.00
Ciz1, a p21 cip1/Waf1-interacting zinc finger protein and DNA replication factor, is a novel molecular partner for human enhancer of rudimentary homolog. FEBS J (2007) 0.99
Weak binding affinity of human 4EHP for mRNA cap analogs. RNA (2007) 0.98
Mass spectrometric analysis of the N terminus of translational initiation factor eIF4G-1 reveals novel isoforms. J Biol Chem (2002) 0.98
mRNAs containing the histone 3' stem-loop are degraded primarily by decapping mediated by oligouridylation of the 3' end. RNA (2012) 0.98
Biophysical approach to studies of cap-eIF4E interaction by synthetic cap analogs. Methods Enzymol (2007) 0.97
Phosphorylation of Mnk1 by caspase-activated Pak2/gamma-PAK inhibits phosphorylation and interaction of eIF4G with Mnk. J Biol Chem (2004) 0.96
Alpha/beta interferon inhibits cap-dependent translation of viral but not cellular mRNA by a PKR-independent mechanism. J Virol (2007) 0.96
DNA hypomethylation affects cancer-related biological functions and genes relevant in neuroblastoma pathogenesis. PLoS One (2012) 0.95
Structural basis for nematode eIF4E binding an m(2,2,7)G-Cap and its implications for translation initiation. Nucleic Acids Res (2011) 0.95
In vivo translation and stability of trans-spliced mRNAs in nematode embryos. Mol Biochem Parasitol (2007) 0.95
Characterization of hMTr1, a human Cap1 2'-O-ribose methyltransferase. J Biol Chem (2010) 0.94
Structural changes of eIF4E upon binding to the mRNA 5' monomethylguanosine and trimethylguanosine Cap. Biochemistry (2008) 0.94
The g5R (D250) gene of African swine fever virus encodes a Nudix hydrolase that preferentially degrades diphosphoinositol polyphosphates. J Virol (2002) 0.93
Phosphorothioate cap analogs stabilize mRNA and increase translational efficiency in mammalian cells. RNA (2007) 0.93
Establishment of an in vitro trans-splicing system in Trypanosoma brucei that requires endogenous spliced leader RNA. Nucleic Acids Res (2010) 0.93
Cap-binding activity of an eIF4E homolog from Leishmania. RNA (2004) 0.93
The nematode eukaryotic translation initiation factor 4E/G complex works with a trans-spliced leader stem-loop to enable efficient translation of trimethylguanosine-capped RNAs. Mol Cell Biol (2010) 0.92
Kinetic mechanism for assembly of the m7GpppG.eIF4E.eIF4G complex. J Biol Chem (2008) 0.92
Eukaryotic initiation factor 4E-3 is essential for meiotic chromosome segregation, cytokinesis and male fertility in Drosophila. Development (2012) 0.92
Evolutionary changes in the Leishmania eIF4F complex involve variations in the eIF4E-eIF4G interactions. Nucleic Acids Res (2009) 0.92
Duration processing in children as determined by time reproduction: implications for a few seconds temporal window. Acta Psychol (Amst) (2002) 0.90
The TbMTr1 spliced leader RNA cap 1 2'-O-ribose methyltransferase from Trypanosoma brucei acts with substrate specificity. J Biol Chem (2007) 0.90
Cap analog substrates reveal three clades of cap guanine-N2 methyltransferases with distinct methyl acceptor specificities. RNA (2009) 0.90
Insulin and prolactin synergistically stimulate beta-casein messenger ribonucleic acid translation by cytoplasmic polyadenylation. Mol Endocrinol (2004) 0.90
Translational regulation of milk protein synthesis at secretory activation. J Mammary Gland Biol Neoplasia (2007) 0.89
Chemical synthesis and binding activity of the trypanosomatid cap-4 structure. RNA (2004) 0.89
Synthesis of anti-reverse cap analogs (ARCAs) and their applications in mRNA translation and stability. Methods Enzymol (2007) 0.88
Preparation of synthetically challenging nucleotides using cyanoethyl P-imidazolides and microwaves. Org Lett (2012) 0.88
The antiviral drug ribavirin does not mimic the 7-methylguanosine moiety of the mRNA cap structure in vitro. RNA (2005) 0.88
A C. elegans eIF4E-family member upregulates translation at elevated temperatures of mRNAs encoding MSH-5 and other meiotic crossover proteins. J Cell Sci (2010) 0.88
Charge distribution in 7-methylguanine regarding cation-pi interaction with protein factor eIF4E. Biophys J (2003) 0.88
Diverse role of three tyrosines in binding of the RNA 5' cap to the human nuclear cap binding complex. J Mol Biol (2008) 0.86
7-methylguanosine diphosphate (m(7)GDP) is not hydrolyzed but strongly bound by decapping scavenger (DcpS) enzymes and potently inhibits their activity. Biochemistry (2012) 0.86